ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Clinical trials for ACUTE PROMYELOCYTIC LEUKEMIA (APL) explained in plain language.
Never miss a new study
Get alerted when new ACUTE PROMYELOCYTIC LEUKEMIA (APL) trials appear
Sign up with your email to follow new studies for ACUTE PROMYELOCYTIC LEUKEMIA (APL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a pill replace IV drips for leukemia patients?
Disease control Not yet recruitingThis phase 3 trial is testing whether an oral (pill) form of arsenic trioxide works as well as the standard IV form for consolidation therapy in people with a low-risk type of acute promyelocytic leukemia (APL). About 120 adults and teens who have already completed initial treatm…
Matched conditions: ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Phase: PHASE3 • Sponsor: SDK Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug aims to stop deadly complication in leukemia therapy
Prevention Not yet recruitingThis study tests whether the drug Lisaftoclax can prevent differentiation syndrome (DS), a severe and sometimes life-threatening side effect, in people with acute promyelocytic leukemia (APL) who are receiving standard treatment. About 60 participants aged 16 and older will take …
Matched conditions: ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Phase: PHASE2, PHASE3 • Sponsor: The Affiliated People's Hospital of Ningbo University • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC